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    Abstract: Introduction : Acinetobacter  is  an  opportunistic  bacterial  pathogen  
primarily  associated  with  Hospital-acquired  infections.  Multi-drug   Resistant  
(MDR)  Acinetobacter  has  increasingly  become  a  formidable  antigen  in  nosocomial  
and  community  acquired  infections. So  much  so,  that  in   recent  years  it  has  been  
designated  as  a  red  alert  human  pathogen  generating  alarm  among  the  medical  
personnel.Aim:The  aim  of  the  study  is  to  isolate , identify  the  Acinetobacter  
species  from  various  clinical  samples  and   to  demonstrate   its  antimicrobial  
resistance  pattern    with  special  emphasis  on  molecular characterization  of  
Carbapenemase  producing  strains  in  our  hospital. Materials  and  methods: Total  
103  isolates  of  Acinetobacter  species  were  isolated.They  were  tested  for  ESBL  
and  CARBAPENEMASE  production  by  phenotypic  and  genotypic  methods. 
Results ; Acinetobacter  species  was  the  most  common  species  isolated.ESBL  
producers  were  45%.Multi-  drug  resistant  was    40%.XDR  were  20%. Acinetobacter  
species  showed  high  level  resistance  to  Cephalosporins,Aminoglycosides  and  
Fluoroquinolones.20%  of  isolates  were   Carbapenem  resistant  and  they   were  
subjected  to  phenotypic  methods  such  as  Modified  Hodge  test    and  Double  disk  
synergy  test.75%  of  isolates  were  positive  by  Modified   Hodge  test. Molecular  
characterisation  of  OXA-Carbapenemases  and  MBL  was  done. It  was  found  that  
OXA-51   and  OXA-23  were  present     100%   in  20  of  Carbapenem  resistant  
isolates .blaVIM  and  blaIMP   were  also  identified  .blaVIM   was  present   in  10%  of  
isolates. CONCLUSION : Acinetobacter  is  recently  emerging  as  a  major  cause  of  
Hospital  acquired  infections. Its  ability  to  cause  infection  in  the  healthy  host  and  
to  develop  multi-drug   resistance  is  of  grave  concern. Among  them  A.baumannii  
is  the  most  frequently  encountered  species  which  is  commonly  associated  with  
ICU  infections  and  a  high  mortality  rate. Now  a  days  emerging  resistance  to  the  
Carbapenem  drug  has  become  a  challenge  to  treat  the  patients . Hence  therapeutic  
options  are  limited  to  last  line   antimicrobials  like  Colistin  and  Polymyxin. 
Treatment  with  these  drugs  are  not  without  adversities. Carbapenem  resistance  in  
A.baumannii  is  due   to  OXA  Carbapenemases blaOXA-23  and  blaOXA-51.   Hence  
phenotypic  identification  and  molecular  characterization of  these  resistant  isolates  
is  necessary. The  only  alternative  left  is  stringent  infection  control  plus  antibiotic  
stewardship  program  which  limits  the  spread  of  resistant  mechanisms  by  using  
the  available  antimicrobials. A  simultaneous  existence  of  different   classes  of  
Carbapenemases  is  a   major  problem  to  encounter  with  and  hence  detection  
methods  are  required  for  each  of  these. In  outbreaks  ,  an  initial  screening  of  the    
Carbapenemase  producers  will  help  to  organize  interventions  and  early  therapies. 
Further  awareness  should  be  created  to  good  housekeeping  and  control  of  the  
equipment ,  including  equipment  decontamination. Strict  attention  to  hand washing  
should   be  undertaken  to  control  the  spread  of  Acinetobacter  in  Hospitals.  
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